Browsing Tag
Europe
151 posts
Ballard Power Systems (BLDP) stock jumps as Solaris backs FCmove-SC for next hydrogen bus platform
Hydrogen buses need better economics. Solaris just backed Ballard Power Systems’ FCmove-SC. Can BLDP turn validation into scale?
Is The Estée Lauder Companies quietly rebuilding its skin care future through 111SKIN?
The Estée Lauder Companies backs 111SKIN as clinical luxury skin care gains momentum. Find out why this minority stake matters.
Telix Pharmaceuticals (TLX) gains European review momentum for TLX101-Px brain cancer imaging candidate
Telix has a glioma imaging gap to fill. Europe’s TLX101-Px review could test whether radiopharma can move beyond prostate cancer.
Unilever PLC (LSE: ULVR) reports 3.8% underlying sales growth as Dove, India and Home Care drive Q1
Unilever volumes are recovering, but currency and portfolio risk remain. Can ULVR turn simplification into a cleaner growth story?
Adidas Q1 2026 beats Street with €705m operating profit and 14% currency-neutral growth as ADS Xetra rallies 9% on FIFA World Cup tailwind
Adidas beat Q1 2026 consensus with €705m operating profit, but held 2026 guidance flat. The unbooked €300m tariff item is the real story for ADS investors.
Associated British Foods (LSE: ABF) faces investor test as Primark split lands alongside 18% profit decline
Primark may unlock value outside ABF. But Sugar losses, Europe weakness and Middle East risk make the split harder than the headline suggests.
PL-Universe Robotics uses Hannover Messe debut to test European appetite for embodied AI manufacturing robots
Europe needs flexible factories. PL-Universe Robotics is betting embodied AI robots can turn that pressure into a new automation market.
Interclean Amsterdam 2026: Jtibot is betting Europe’s labour crunch will make outdoor sweepers smarter, not smaller
Europe needs cleaner large sites with fewer workers. Jtibot’s autonomous sweeper push turns facility pressure into a robotics test case.
Procter & Gamble (NYSE: PG) beats Q3 estimates on beauty momentum but Andre Schulten flags billion-dollar oil headwind for fiscal 2027
Procter & Gamble beat Q3 estimates, but a $1 billion fiscal 2027 oil warning is the harder question for investors banking on a clean earnings reset.
Gujarat Themis Biosyn (GUJTHEM) bets on global branded generics with €158m Sanofi portfolio deal
Find out how Gujarat Themis Biosyn’s €158m Sanofi portfolio deal could reshape its global anti-infective growth strategy.